Adaptive Biotechnologies Corporation
(ADPT - NASDAQ)
14,21 USD
📋 Profilo Aziendale

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

|